Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat

Molecular Cloning: A Laboratory Manual

Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589 · see citing works

A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity

Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,512 · see citing works

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease

Chirgwin, J. M., Przybyla, A., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725 · see citing works

A simple and very efficient method for generating cDNA libraries

Gubler, U., & Hoffman, B. J. (1983) · Gene · doi:10.1016/0378-1119(83)90230-5 · Cited by 4,461 · see citing works

Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.

Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., & Barnes, C. L. (1984) · Science · doi:10.1126/science.6474172 · Cited by 2,268 · see citing works

Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells

Nadler, J. V., Perry, B. W., & Cotman, C. W. (1978) · Nature · doi:10.1038/271676a0 · Cited by 745 · see citing works

Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease

Rogers, J., Luber-Narod, J., Styren, S. D., & Civin, W. H. (1988) · Neurobiology of Aging · doi:10.1016/s0197-4580(88)80079-4 · Cited by 743 · see citing works

Perforant pathway changes and the memory impairment of Alzheimer's disease

Hyman, B. T., Van Hoesen, G. W., Kromer, L. J., & Damasio, A. R. (1986) · Annals of Neurology · doi:10.1002/ana.410200406 · Cited by 672 · see citing works

Developmentally regulated expression of specific tau sequences

Kosik, K. S., Orecchio, L. D., Bakalis, S., & Neve, R. L. (1989) · Neuron · doi:10.1016/0896-6273(89)90077-9 · Cited by 598 · see citing works

Plasticity of Hippocampal Circuitry in Alzheimer's Disease

Geddes, J. W., Monaghan, D. T., Cotman, C. W., Lott, I. T., Kim, R. C., & Chui, H. C. (1985) · Science · doi:10.1126/science.4071042 · Cited by 461 · see citing works

Immune System Response in Alzheimer's Disease

McGeer, P. L., Akiyama, H., Itagaki, S., & McGeer, E. G. (1989) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100029863 · Cited by 460 · see citing works

Induction of the TRPM-2 gene in cells undergoing programmed death.

Buttyan, R., Olsson, C. A., Pintar, J. E., Chang, C., Bandyk, M., Ng, P. Y., & Sawczuk, I. S. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.8.3473 · Cited by 452 · see citing works

Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: identity to sulfated glycoprotein 2, a constituent of rat testis fluid.

Jenne, D. E., & Tschopp, J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.18.7123 · Cited by 414 · see citing works

Biosynthesis and molecular cloning of sulfated glycoprotein 2 secreted by rat Sertoli cells

Collard, M. W., & Griswold, M. D. (1987) · Biochemistry · doi:10.1021/bi00386a008 · Cited by 334 · see citing works

Complement activation in amyloid plaques in Alzheimer’s dementia

Eikelenboom, P., Hack, C. E., Rozemüller, A. J. M., & Stam, F. C. (1988) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02890024 · Cited by 288 · see citing works

Neurofilament and tubulin expression recapitulates the developmental program during axonal regeneration: induction of a specific beta-tubulin isotype.

Hoffman, P. N., & Cleveland, D. W. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4530 · Cited by 278 · see citing works

Cell Biology of Synaptic Plasticity

Cotman, C. W., & Nieto‐Sampedro, M. (1984) · Science · doi:10.1126/science.6382610 · Cited by 273 · see citing works

Changes in brain gene expression shared by scrapie and Alzheimer disease.

Duguid, J. R., Bohmont, C. W., Liu, N. G., & Tourtellotte, W. W. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.18.7260 · Cited by 251 · see citing works

Molecular cloning and characterization of the novel, human complement‐associated protein, SP‐40,40: a link between the complement and reproductive systems.

Kirszbaum, L., Sharpe, J. A., Murphy, B., D'Apice, A. J. F., Classon, B. J., Hudson, P. J., & Walker, I. D. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03430.x · Cited by 238 · see citing works

The neuropathology of Alzheimer's disease: A review with pathogenetic, aetiological and therapeutic considerations

Mann, D. M. A. (1985) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(85)90092-2 · Cited by 202 · see citing works

Identification of an androgen-repressed mRNA in rat ventral prostate as coding for sulphated glycoprotein 2 by cDNA cloning and sequence analysis

Bettuzzi, S., Hiipakka, R. A., Gilna, P., & Liao, S. (1989) · Biochemical Journal · doi:10.1042/bj2570293 · Cited by 182 · see citing works

Immuno-electron-microscopic localization of complements in amyloid fibrils of senile plaques

Ishii, T., & Haga, S. (1984) · Acta Neuropathologica · doi:10.1007/bf00687336 · Cited by 172 · see citing works

Synaptic plasticity and functional stabilization in the hippocampal formation: possible role in Alzheimer's disease.

Cotman, C. W., & Anderson, K. J. (1988) · PubMed · Cited by 105 · see citing works

Reexpression of a developmentally regulated antigen in Down syndrome and Alzheimer disease.

Wolozin, B. L., Scicutella, A., & Davies, P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.16.6202 · Cited by 104 · see citing works

Selective reduction of mRNA for the β-amyloid precursor protein that lacks a Kunitz-type protease inhibitor motif in cortex from Alzheimer brains☆

Johnson, S. A., Pasinetti, G. M., May, P. C., Ponte, P. A., Cordell, B., & Finch, C. E. (1988) · Experimental Neurology · doi:10.1016/0014-4886(88)90104-5 · Cited by 98 · see citing works

Cloning of hippocampal poly(A) RNA sequences that increase after entorhinal cortex lesion in adult rat

Poirier, J., Hess, M. A., May, P. C., & Finch, C. E. (1991) · Molecular Brain Research · doi:10.1016/0169-328x(91)90002-f · Cited by 90 · see citing works

Altered Gene Expression in Alzheimer's Disease Brain Tissue

May, P. C., Johnson, S. A., Poirier, J., Lampert-Etchells, M., & Finch, C. E. (1989) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100029796 · Cited by 73 · see citing works

Increased expression of the embryonic form of a developmentally regulated mRNA in Alzheimer's disease

Geddes, J. W., Wong, J. C. T., Choi, B. H., Kim, R. C., Cotman, C. W., & Miller, F. D. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90537-j · Cited by 59 · see citing works

Selective alterations of RNA in rat hippocampus after entorhinal cortex lesioning.

Poirier, J., May, P. C., Osterburg, H. H., Geddes, J. W., Cotman, C. W., & Finch, C. E. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.1.303 · Cited by 56 · see citing works

Diffusible, nonfibrillar ligands derived from Aβ _1–42 are potent central nervous system neurotoxins

Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506 · see citing works

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326 · see citing works

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234 · see citing works

Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis

Karch, C. M., & Goate, A. M. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.006 · Cited by 1,357 · see citing works

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases

MCGEER, P., & MCGEER, E. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00011-9 · Cited by 1,287 · see citing works

GFAP in health and disease

Middeldorp, J., & Hol, E. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.01.005 · Cited by 1,080 · see citing works

Complement activation by beta-amyloid in Alzheimer disease.

Rogers, J., Cooper, N. R., Webster, S., Schultz, J., McGeer, P. L., Styren, S. D., Civin, W. H., Brachova, L., Bradt, B., & Ward, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10016 · Cited by 817 · see citing works

Microglia in degenerative neurological disease

McGeer, P. L., Kawamata, T., Walker, D. G., Akiyama, H., Tooyama, I., & McGeer, E. G. (1993) · Glia · doi:10.1002/glia.440070114 · Cited by 595 · see citing works

Cholesterol metabolism in neurons and astrocytes

Pfrieger, F. W., & Ungerer, N. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.06.002 · Cited by 500 · see citing works

Inflammation and Alzheimer's disease pathogenesis

Rogers, J., Webster, S. D., Lue, L., Brachova, L., CIVIN, W. H., Emmerling, M. R., Shivers, B. D., Walker, D. G., & McGeer, P. L. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00115-7 · Cited by 441 · see citing works

Autophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications

Uddin, M. S., Stachowiak, A., Mamun, A. A., Tzvetkov, N. T., Takeda, S., Atanasov, A. G., Bergantin, L. B., Abdel‐Daim, M. M., & Stankiewicz, A. M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00004 · Cited by 440 · see citing works

Clusterin: Physiologic and pathophysiologic considerations

Rosenberg, M. E., & Silkensen, J. R. (1995) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/1357-2725(95)00027-m · Cited by 427 · see citing works

Transthyretin sequesters amyloid beta protein and prevents amyloid formation.

Schwarzman, A. L., Gregori, L. L., Vitek, M. P., Lyubski, S., Strittmatter, W. J., Enghilde, J. J., Bhasin, R., Silverman, J. M., Weisgraber, K. H., & Coyle, P. K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8368 · Cited by 410 · see citing works

GFAP mRNA increases with age in rat and human brain

Nichols, N. R., Day, J. R., Laping, N. J., Johnson, S. A., & Finch, C. E. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90100-p · Cited by 413 · see citing works

Therapeutic potential of mood stabilizers lithium and valproic acid:Beyond bipolar disorder

Chiu, C.-T., Wang, Z., Hunsberger, J. G., & Chuang, D.-M. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005512 · Cited by 404 · see citing works

Clusterin in Alzheimer’s Disease: Mechanisms, Genetics, and Lessons From Other Pathologies

Foster, E. M., Dangla-Valls, A., Lovestone, S., Ribe, E. M., & Buckley, N. J. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00164 · Cited by 381 · see citing works

Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning

Poirier, J., Hess, M. A., May, P. C., & Finch, C. E. (1991) · Molecular Brain Research · doi:10.1016/0169-328x(91)90111-a · Cited by 380 · see citing works

Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease

DeMattos, R. B., O'dell, M. A., Parsadanian, M., Taylor, J. W., Harmony, J. A. K., Bales, K. R., Paul, S. M., Aronow, B. J., & Holtzman, D. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162228299 · Cited by 359 · see citing works

Clusterin: the intriguing guises of a widely expressed glycoprotein

Jenne, D. E., & Tschopp, J. (1992) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(92)90325-4 · Cited by 347 · see citing works

Complement components of the innate immune system in health and disease in the CNS

Gasque, P., Dean, Y. D., McGreal, E. P., VanBeek, J., & Morgan, B. P. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)80302-1 · Cited by 343 · see citing works

Proteomic Characterization of Postmortem Amyloid Plaques Isolated by Laser Capture Microdissection

Liao, L., Cheng, D., Wang, J., Duong, D. M., Losik, T. G., Gearing, M., Rees, H. D., Lah, J. J., Levey, A. I., & Peng, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403672200 · Cited by 323 · see citing works

Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease

Puchades, M. A., Hansson, S., Nilsson, C. L., Andreasen, N., Blennow, K., & Davidsson, P. (2003) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.08.005 · Cited by 306 · see citing works

The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE

Guerreiro, R. J., Gustafson, D. R., & Hardy, J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.03.025 · Cited by 285 · see citing works

Caspase-6 Role in Apoptosis of Human Neurons, Amyloidogenesis, and Alzheimer's Disease

LeBlanc, A. C., Liu, H., Goodyer, C. G., Bergeron, C., & Hammond, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23426 · Cited by 279 · see citing works

Active cell death in hormone-dependent tissues

Tenniswood, M., Guenette, R. S., Lakins, J. N., Mooibroek, M. J., WONG, P. W. K., & Welsh, J. (1992) · Cancer and Metastasis Reviews · doi:10.1007/bf00048064 · Cited by 261 · see citing works

Molecular and Cellular Characterization of the Membrane Attack Complex, C5b-9, in Alzheimer’s Disease

Webster, S. D., Lue, L., Brachova, L., Tenner, A. J., McGeer, P. L., Terai, K., Walker, D. G., Bradt, B. M., Cooper, N. R., & Rogers, J. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00042-0 · Cited by 258 · see citing works

Extracellular protein components of amyloid plaques and their roles in Alzheimer’s disease pathology

Rahman, M. M., & Lendel, C. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00465-0 · Cited by 245 · see citing works

Increased Synaptic Sprouting in Response to Estrogen via an Apolipoprotein E-Dependent Mechanism: Implications for Alzheimer’s Disease

Stone, D. J., Rozovsky, I., Morgan, T. E., Anderson, C. P., & Finch, C. E. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-09-03180.1998 · Cited by 237 · see citing works

Clusterin: A forgotten player in Alzheimer's disease

Nuutinen, T., Suuronen, T., Kauppinen, A., & Salminen, A. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.05.007 · Cited by 267 · see citing works

Cholesterol homeostasis in neurons and glial cells

Vance, J. E., Hayashi, H., & Karten, B. (2005) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2005.01.005 · Cited by 222 · see citing works

Identification of Glycoprotein 330 as an Endocytic Receptor for Apolipoprotein J/Clusterin

Kounnas, M. Z., Loukinova, E. B., Stefansson, S., Harmony, J. A. K., Brewer, B., Strickland, D. K., & Argraves, W. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.13070 · Cited by 225 · see citing works

Plasma clusterin and the risk of Alzheimer disease

Schrijvers, E. M. C. (2011) · JAMA · doi:10.1001/jama.2011.381 · Cited by 220 · see citing works

Distribution of clusterin in Alzheimer brain tissue

McGeer, P. L., Kawamata, T., & Walker, D. G. (1992) · Brain Research · doi:10.1016/0006-8993(92)90071-g · Cited by 212 · see citing works

Electron microscopic analysis of adrenalectomy‐induced hippocampal granule cell degeneration in the rat: Apoptosis in the adult central nervous system

Sloviter, R. S., Dean, E., & Neubort, S. (1993) · The Journal of Comparative Neurology · doi:10.1002/cne.903300305 · Cited by 212 · see citing works

Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease

Bertrand, P., Poirier, J., Oda, T., Finch, C. E., & Pasinetti, G. M. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00097-c · Cited by 210 · see citing works

Complement Biosynthesis in the Central Nervous System

Barnum, S. R. (1995) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411950060020301 · Cited by 207 · see citing works

Clusterin contributes to caspase-3–independent brain injury following neonatal hypoxia-ischemia

Han, B. H., Demattos, R. B., Dugan, L. L., Kim‐Han, J. S., Brendza, R. P., Fryer, J. D., Kierson, M., Cirrito, J. R., Quick, K. L., Harmony, J. A. K., et al. (2001) · Nature Medicine · doi:10.1038/85487 · Cited by 206 · see citing works

Apolipoproteins in the brain: implications for neurological and psychiatric disorders

Elliott, D. A., Weickert, C. S., & Garner, B. (2010) · Clinical Lipidology · doi:10.2217/clp.10.37 · Cited by 196 · see citing works

Apolipoprotein J expression at fluid-tissue interfaces: potential role in barrier cytoprotection.

Aronow, B. J., Lund, S., Brown, T. L., Harmony, J. A. K., & Witte, D. P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.725 · Cited by 198 · see citing works

Characterization of Apolipoprotein J-Alzheimer's Aβ Interaction

Matsubara, E., Frangione, B., & Ghiso, J. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7563 · Cited by 195 · see citing works

Stress-induced transcription of the clusterin/apoJ gene

Michel, D., Chatelain, G., North, S., & Brun, G. (1997) · Biochemical Journal · doi:10.1042/bj3280045 · Cited by 194 · see citing works

The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease

Beffert, U. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00008-3 · Cited by 188 · see citing works

Extracellular Chaperones and Proteostasis

Wyatt, A. R., Yerbury, J. J., Ecroyd, H. W., & Wilson, M. R. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-072711-163904 · Cited by 180 · see citing works

Clusterin Gene Expression Mediates Resistance to Apoptotic Cell Death Induced by Heat Shock and Oxidative Stress

Viard, I., Wehrli, P., Jornot, L., Bullani, R. R., Vechietti, J.-L., French, L. E., Schifferli, J. A., & Tschopp, J. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00531.x · Cited by 181 · see citing works

Complement mRNA in the mammalian brain: Responses to Alzheimer's disease and experimental brain lesioning

Johnson, S. A., Lampert-Etchells, M., Pasinetti, G. M., Rozovsky, I., & Finch, C. E. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90086-d · Cited by 177 · see citing works

The Role of Clusterin in Alzheimer’s Disease: Pathways, Pathogenesis, and Therapy

Yu, J.-T., & Tan, L. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8237-1 · Cited by 174 · see citing works

Sulfated glycoprotein 2: new relationships of this multifunctional protein to neurodegeneration

May, P. C., & Finch, C. E. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90190-j · Cited by 170 · see citing works

Current status on Alzheimer disease molecular genetics: from past, to present, to future

Bettens, K., Sleegers, K., & Broeckhoven, C. V. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq142 · Cited by 167 · see citing works

Complement gene expression in human brain: comparison between normal and Alzheimer disease cases

Walker, D. G., & McGeer, P. L. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90017-6 · Cited by 167 · see citing works

Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease

Kalman, J. L., Juhász, A., Laird, G., Dickens, P., Járdánházy, T., Rimanóczy, Á., Boncz, I., Parry-Jones, W. L., & Janka, Z. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1997.tb00275.x · Cited by 167 · see citing works

Clusterin (Apolipoprotein J) Protein Levels Are Increased in Hippocampus and in Frontal Cortex in Alzheimer's Disease

Lidström, A.-M., Bogdanović, N., Hesse, C., Volkmann, I., Davidsson, P., & Blennow, K. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6892 · Cited by 163 · see citing works

More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration

Lane-Donovan, C., Philips, G. T., & Herz, J. (2014) · Neuron · doi:10.1016/j.neuron.2014.08.005 · Cited by 158 · see citing works

APOE and cholesterol homeostasis in Alzheimer's disease

Leduc, V., Jasmin, S. B., & Poirier, J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.07.008 · Cited by 158 · see citing works

Human clusterin gene expression is confined to surviving cells during in vitro programmed cell death.

French, L. E., Wohlwend, A., Sappino, A. P., Tschopp, J., & Schifferli, J. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117043 · Cited by 160 · see citing works

Molecular characterization of human TRPM‐2/clusterin, a gene associated with sperm maturation, apoptosis and neurodegeneration

WONG, P. W. K., Taillefer, D., Lakins, J. N., Pineault, J. M., Chader, G. J., & Tenniswood, M. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18807.x · Cited by 159 · see citing works

Clusterin (SGP‐2): A multifunctional glycoprotein with regional expression in astrocytes and neurons of the adult rat brain

Pasinetti, G. M., Johnson, S. A., Oda, T., Rozovsky, I., & Finch, C. E. (1994) · The Journal of Comparative Neurology · doi:10.1002/cne.903390307 · Cited by 154 · see citing works

Late-Onset Alzheimer’s Disease Genes and the Potentially Implicated Pathways

Rosenthal, S. L., & Kamboh, M. I. (2014) · Current Genetic Medicine Reports · doi:10.1007/s40142-014-0034-x · Cited by 153 · see citing works

Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways

Wojtas, A., Kang, S. S., Olley, B. M., Gatherer, M., Shinohara, M., Lozano, P. A., Liu, C., Kurti, A., Baker, K. E., Dickson, D. W., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701137114 · Cited by 151 · see citing works

Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo.

Miyake, H., Chi, K. N., & Gleave, M. E. (2000) · PubMed · Cited by 150 · see citing works

Microglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets

Nizami, S., Hall‐Roberts, H., Warrier, S., Cowley, S. A., & Di Daniel, E. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14618 · Cited by 147 · see citing works

Enhanced radiation sensitivity in prostate cancer by inhibition of the cell survival protein clusterin.

Zellweger, T., Chi, K., Miyake, H., Adomat, H. H., Kiyama, S., Skov, K. A., & Gleave, M. E. (2002) · PubMed · Cited by 147 · see citing works

Clusterin as a therapeutic target

Wilson, M. R., & Zoubeidi, A. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1267142 · Cited by 141 · see citing works

Programmed cell death: Implications for neuropsychiatric disorders

Margolis, R. L., Chuang, D., & Post, R. M. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)91241-6 · Cited by 144 · see citing works

In Vivo Effects of ApoE and Clusterin on Amyloid-β Metabolism and Neuropathology

Holtzman, D. M. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:23:3:247 · Cited by 138 · see citing works

Complement C1qB and C4 mRNAs responses to lesioning in rat brain

Pasinetti, G. M., Johnson, S. A., Rozovsky, I., Lampert-Etchells, M., Morgan, D., Gordon, M. N., Morgan, T. E., Willoughby, D., & Finch, C. E. (1992) · Experimental Neurology · doi:10.1016/0014-4886(92)90028-o · Cited by 138 · see citing works

Antitumor Activity of Antisense Clusterin Oligonucleotides Is Improved in Vitro and in Vivo by Incorporation of 2′-O-(2-Methoxy)Ethyl Chemistry

Zellweger, T., Miyake, H., Cooper, S. R., Chi, K., Conklin, B., Monia, B. P., & Gleave, M. E. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29459-3 · Cited by 133 · see citing works

Genetic markers for diagnosis and pathogenesis of Alzheimer's disease

Kim, D., Yeo, S. H., Park, J.-M., Choi, J. Y., Lee, T.-H., Park, S. Y., Ock, M. S., Eo, J., Kim, H., & Cha, H. (2014) · Gene · doi:10.1016/j.gene.2014.05.031 · Cited by 128 · see citing works

Murine clusterin: molecular cloning and mRNA localization of a gene associated with epithelial differentiation processes during embryogenesis

French, L. E., Chonn, A., Ducrest, D., Baumann, B., Belin, D., Wohlwend, A., Kiss, J., Sappino, A.-P., Tschopp, J., & Schifferli, J. A. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.122.5.1119 · Cited by 125 · see citing works

Elevated levels of the complement components C3 and factor B in ventricular cerebrospinal fluid of patients with traumatic brain injury

Kossmann, T., Stahel, P. F., Morganti-Kossmann, M. C., Jones, J. L., & Barnum, S. R. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00164-6 · Cited by 124 · see citing works

Behavioural, physiological and morphological analysis of a line of apolipoprotein E knockout mouse

Anderson, R., Barnes, J. C., Bliss, T. V. P., Cain, D. P., Cambon, K., Davies, H. A., Errington, M. L., Fellows, L. A., Gray, R. A., Hoh, T., et al. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00598-8 · Cited by 119 · see citing works

The lurcher gene induces apoptotic death in cerebellar Purkinje cells

Norman, D. J., Feng, L., Cheng, S. S., Gubbay, J., Chan, E. W., & Heintz, N. (1995) · Development · doi:10.1242/dev.121.4.1183 · Cited by 116 · see citing works

Characterization of the AD7C-NTP cDNA expression in Alzheimer's disease and measurement of a 41-kD protein in cerebrospinal fluid.

Monte, S., Ghanbari, K., Frey, W. H., Beheshti, I., Averback, P., Hauser, S., Ghanbari, H., & Wands, J. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119864 · Cited by 125 · see citing works

Apoptosis in the developing CNS

Naruse, I., & Keino, H. (1995) · Progress in Neurobiology · doi:10.1016/0301-0082(95)00024-p · Cited by 115 · see citing works

Activation of the complement cascade and increase of clusterin in the brain following a cortical contusion in the adult rat

Bellander, B., von Holst, H., Fredman, P., & Svensson, M. A. (1996) · Journal of neurosurgery · doi:10.3171/jns.1996.85.3.0468 · Cited by 112 · see citing works

Castration Enhances Expression of Glial Fibrillary Acidic Protein and Sulfated Glycoprotein-2 in the Intact and Lesion-Altered Hippocampus of the Adult Male Rat

Day, J. R., Laping, N. J., McNeill, T. H., Schreiber, S. S., Pasinetti, G. M., & Finch, C. E. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-12-1995 · Cited by 113 · see citing works

The Genetics of Alzheimer’s Disease

Barber, R. C. (2012) · Scientifica · doi:10.6064/2012/246210 · Cited by 111 · see citing works

Differential regulation of brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase messenger RNA expression in Alzheimer's disease

Murray, K. D., Gall, C. M., Jones, E. G., & Isackson, P. J. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90202-x · Cited by 110 · see citing works

Clusterin Biogenesis Is Altered during Apoptosis in the Regressing Rat Ventral Prostate

Lakins, J. N., Bennett, S. A. L., Chen, J.-H., Arnold, J. M., Morrissey, C. M., WONG, P. W. K., O'Sullivan, J. N., & Tenniswood, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.27887 · Cited by 107 · see citing works

Clusterin: A Role in Cell Survival in the Face of Apoptosis?

Koch-Brandt, C., & Morgans, C. W. (1996) · Progress in molecular and subcellular biology · doi:10.1007/978-3-642-79850-4_8 · Cited by 104 · see citing works

Transforming growth factor-β1 induces neuronal and astrocyte genes: Tubulin α1, glial fibrillary acidic protein and clusterin

Laping, N. J., Morgan, T. E., Nichols, N. R., Rozovsky, I., Young-Chan, C. S., Zarow, C., & Finch, C. E. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90081-7 · Cited by 102 · see citing works

Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer’s disease neuropathology

Chen, F., Swartzlander, D. B., Ghosh, A., Fryer, J. D., Wang, B., & Zheng, H. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00426-7 · Cited by 99 · see citing works

Lack of correspondence between mRNA expression for a putative cell death molecule (SGP‐2) and neuronal cell death in the central nervous system

Garden, G. A., Bothwell, M. A., & Rubel, E. W. (1991) · Journal of Neurobiology · doi:10.1002/neu.480220605 · Cited by 99 · see citing works

Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer's disease

Poirier, J., Miron, J., Picard, C., Gormley, P., Théroux, L., Breitner, J. C. S., & Dea, D. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.037 · Cited by 98 · see citing works

Functional and structural properties of lipid-associated apolipoprotein J (clusterin)

CALERO, M., TOKUDA, T., ROSTAGNO, A., KUMAR, A., ZLOKOVIC, B., FRANGIONE, B., & GHISO, J. (1999) · Biochemical Journal · doi:10.1042/bj3440375 · Cited by 98 · see citing works

Inflammation and Alzheimer's Disease: Relationships between Pathogenic Mechanisms and Clinical Expression

Eikelenboom, P., Rozemüller, A. J. M., & Muiswinkel, F. L. V. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6920 · Cited by 98 · see citing works

Amyloid β-protein precursor: new clues to the genesis of Alzheimer's disease

Selkoe, D. J. (1994) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(94)90014-0 · Cited by 96 · see citing works

Both common variations and rare non-synonymous substitutions and small insertion/deletions in CLU are associated with increased Alzheimer risk

Bettens, K., Brouwers, N., Engelborghs, S., Lambert, J., Rogaeva, E. A., Vandenberghe, R. R., Bastard, N. L., Pasquier, F., Vermeulen, S., Dongen, J. V., et al. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-3 · Cited by 94 · see citing works

Selective expression of clusterin (SGP-2) and complement C1qB and C4 during responses to neurotoxinsin vivo andin vitro

Rozovsky, I., Morgan, T. E., Willoughby, D. A., Dugich‐Djordjevic, M. M., Pasinetti, G. M., Johnson, S. A., & Finch, C. E. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90473-1 · Cited by 93 · see citing works

The Reelin Receptors Apolipoprotein E receptor 2 (ApoER2) and VLDL Receptor

Dlugosz, P., & Nimpf, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103090 · Cited by 91 · see citing works

Possible neuroprotective role of clusterin in Alzheimer's disease: a quantitative immunocytochemical study

Giannakopoulos, P., Kövari, E., French, L. E., Viard, I., Hof, P. R., & Bouras, C. (1998) · Acta Neuropathologica · doi:10.1007/s004010050815 · Cited by 90 · see citing works

Intracellular Clusterin Interacts with Brain Isoforms of the Bridging Integrator 1 and with the Microtubule-Associated Protein Tau in Alzheimer's Disease

Zhou, Y., Hayashi, I., Wong, J., Tugusheva, K., Renger, J. J., & Zerbinatti, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103187 · Cited by 86 · see citing works

Human gliomas and epileptic foci express high levels of a mRNA related to rat testicular sulfated glycoprotein 2, a purported marker of cell death.

Danik, M., Chabot, J., Mercier, C., Benabid, A., Chauvin, C., Quirion, R., & Suh, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8577 · Cited by 88 · see citing works

Inflammation in Alzheimer’s Disease and Molecular Genetics: Recent Update

Zhang, Z., Li, Y., Ng, C. T., & Song, Y. (2015) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-015-0351-0 · Cited by 87 · see citing works

The early contribution of cerebrovascular factors to the pathogenesis of Alzheimer’s disease

Pimentel‐Coelho, P. M., & Rivest, S. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08126.x · Cited by 85 · see citing works

Identification of molecular aggregates containing glycoproteins III, J, K (carboxypeptidase H), and H (Kex2-related proteases) in the soluble and membrane fractions of adrenal medullary chromaffin granules.

Palmer, D. J., & Christie, D. L. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)88625-8 · Cited by 85 · see citing works

Localization of sulfated glycoprotein‐2/clusterin mRNA in the rat brain by in situ hybridization

Danik, M., Chabot, J., Hassan‐gonzalez, D., Suh, M., & Quirion, R. (1993) · The Journal of Comparative Neurology · doi:10.1002/cne.903340205 · Cited by 84 · see citing works

Mouse apolipoprotein J: characterization of a gene implicated in atherosclerosis.

Jordan-Starck, T. C., Lund, S., Witte, D. P., Aronow, B. J., Ley, C. A., Stuart, W. D., Swertfeger, D. K., Clayton, L., Sells, S. F., & Paigen, B. J. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41208-8 · Cited by 81 · see citing works

The Impact of Cholesterol, DHA, and Sphingolipids on Alzheimer’s Disease

Grimm, M. O. W., Zimmer, V. C., Lehmann, J., Grimm, H. S., & Hartmann, T. (2013) · BioMed Research International · doi:10.1155/2013/814390 · Cited by 81 · see citing works

Clusterin levels are increased in A lzheimer's disease and influence the regional distribution of Aβ

Miners, J. S., Clarke, P., & Love, S. (2016) · Brain Pathology · doi:10.1111/bpa.12392 · Cited by 81 · see citing works

Complement activation and β-amyloid-mediated neurotoxicity in Alzheimer's disease

Rogers, J., Schultz, J., Brachova, L., Lue, L. F., Webster, S. M., Bradt, B. M., Cooper, N. R., & Moss, D. E. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80046-n · Cited by 81 · see citing works

Altered Gene Expression in Alzheimer's Disease Brain Tissue

May, P. C., Johnson, S. A., Poirier, J., Lampert-Etchells, M., & Finch, C. E. (1989) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100029796 · Cited by 73 · see citing works

Neurons express proteins of the classical complement pathway in Alzheimer disease.

Terai, K., Walker, D., Mcgeer, E., & McGeer, P. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00849-4 · Cited by 149 · see citing works

Perforant Path Transection Induces Complement C9 Deposition in Hippocampus

Johnson, S. A., Young-Chan, C. S., Laping, N. J., & Finch, C. E. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0058 · Cited by 29 · see citing works

Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain.

Shen, Y., Li, R.-N., Mcgeer, E., & McGeer, P. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00850-0 · Cited by 213 · see citing works

Deficiency of Complement Defense Protein CD59 May Contribute to Neurodegeneration in Alzheimer's Disease

Yang, L., Li, R., Meri, S., Rogers, J., & Shen, Y. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-20-07505.2000 · Cited by 136 · see citing works